Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0002736 (
amyotrophic lateral sclerosis
)
19,048
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have recently isolated a 2.2-kb cDNA clone (1C5) from a human spinal cord cDNA library with partial identity to the 14-3-3 protein mRNA encoding the theta protein (
YWHAQ
). 14-3-3 protein transcripts are highly expressed in large projection neurones of the hippocampus, cerebellum, and spinal cord and have been found to be significantly up-regulated in rat motor neurones following hypoglossal nerve axotomy. In this study we investigated whether the 1C5 transcript (
YWHAQ
) isolated from spinal cord was involved in
amyotrophic lateral sclerosis
(
ALS
). We found a significant up-regulation of 1C5 (
YWHAQ
) in lumbar spinal cord from patients with sporadic
ALS
compared with controls, with the highest levels of expression being found in individuals with predominant lower motor neurone involvement. A 6-bp tandem repeat in the 5'-untranslated region of the gene was found to be polymorphic, but no significant association with disease was found following genomic analysis of this region. The localisation of 1C5 (
YWHAQ
) to chromosome 2 was determined and coincides with that reported for clone HS1 (EMBL accession no. X57347). These results show the marked up-regulation of the 14-3-3 isoform (
YWHAQ
) in
ALS
spinal cord and indicate the involvement of a potential 14-3-3-mediated survival pathway in the pathogenesis of
ALS
.
...
PMID:A 14-3-3 mRNA is up-regulated in amyotrophic lateral sclerosis spinal cord. 1108 Feb 4